Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Charles River Laboratories Inc
483
•Charles River Laboratories Inc•October 11, 2024

Charles River Laboratories Inc – FDA 483, Oct 11, 2024

Record Details

Charles River Laboratories, Inc., a cell and gene therapy establishment in Memphis, TN, underwent an FDA inspection from October 7-11, 2024. The inspection resulted in an FDA Form 483, detailing significant observations indicating non-compliance with regulatory expectations for pharmaceutical manufacturing.

The primary issues identified included deficient Quality Assurance oversight, particularly in the timely management of deviations. The firm was observed to have delays in initiating, investigating, and closing deviations, as well as in implementing corrective actions. Examples included critical temperature units used for materials not being requalified for several years, and critical deviation investigations remaining open past permitted extensions.

Moreover, the FDA noted that environmental controls and manufacturing processes were insufficient to ensure product sterility. This was demonstrated by multiple product microbial contamination events coinciding with numerous environmental monitoring excursions in critical production areas. Preventative actions were not identified or effectively implemented, and a critical raw material lacked a validated sterilization process. Additionally, the firm's procedures for testing and qualifying raw materials were found to be deficient, as certain components were used in manufacturing without required post-receipt testing.

Charles River Laboratories is required to provide a comprehensive response detailing corrective and preventive actions to address these observations and ensure compliance with the Federal Food, Drug and Cosmetic Act and associated regulations.

Company
Charles River Laboratories Inc
Inspection date
October 11, 2024
Product type
biologics
Office
Office of Compliance and Biologics Quality
People
  • Brenton K. McCright (FDA_PERSONNEL)
  • Grace Forsythia Igot (investigator)
  • Christine Harman
  • Ahmad Hussin (Site Director Charles River Laboratories)
View Company Profile

ID · 97c49f67-f4f5-4f09-bfc2-3e3d25eb14fd

Other documents for Charles River Laboratories Inc
  • 483 - 2025-10-17October 17, 2025
  • 483 - 2025-02-07February 7, 2025
  • 483 - 2023-08-25August 25, 2023
  • EIR - 2020-09-21September 21, 2020
  • EIR - 2019-04-03April 3, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Charles River Laboratories Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.